$142 Billion is the total value of FRANKLIN RESOURCES INC's 3763 reported holdings in Q4 2010. The portfolio turnover from Q3 2010 to Q4 2010 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2010 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2011-02-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 45 | Q2 2024 | 5.2% |
APPLE INC | 45 | Q2 2024 | 2.5% |
AMAZON COM INC | 45 | Q2 2024 | 2.8% |
JPMORGAN CHASE & CO. | 45 | Q2 2024 | 1.6% |
MERCK & CO INC NEW | 45 | Q2 2024 | 2.4% |
CHEVRON CORP NEW | 45 | Q2 2024 | 1.3% |
WELLS FARGO CO NEW | 45 | Q2 2024 | 1.8% |
JOHNSON & JOHNSON | 45 | Q2 2024 | 1.2% |
PEPSICO INC | 45 | Q2 2024 | 1.1% |
PFIZER INC | 45 | Q2 2024 | 1.5% |
View FRANKLIN RESOURCES INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Innoviva, Inc. | May 13, 2024 | 6,412,700 | 10.2% |
Integra Resources Corp. | April 09, 2024 | 8,498,181 | 12.1% |
ACHIEVE LIFE SCIENCES, INC. | March 11, 2024 | 4,365,755 | 12.0% |
Acumen Pharmaceuticals, Inc. | February 06, 2024 | 3,358,809 | 5.8% |
Applied Therapeutics Inc. | February 06, 2024 | 7,793,912 | 10.0% |
Bridge Investment Group Holdings Inc. | February 06, 2024 | 1,550,974 | 4.5% |
Cullinan Oncology, Inc. | February 06, 2024 | 3,281,280 | 7.7% |
DXC Technology Co | February 06, 2024 | 8,220,896 | 4.2% |
EyePoint Pharmaceuticals, Inc. | February 06, 2024 | 4,640,651 | 9.5% |
Galiano Gold Inc. | February 06, 2024 | 8,207,262 | 3.6% |
View FRANKLIN RESOURCES INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-09-23 |
SC 13D/A | 2024-09-20 |
4 | 2024-09-17 |
4 | 2024-09-13 |
SC 13D/A | 2024-09-09 |
4 | 2024-09-04 |
4 | 2024-09-04 |
4 | 2024-09-04 |
4 | 2024-09-04 |
4 | 2024-09-04 |
View FRANKLIN RESOURCES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.